K-Ras mutation status as a predictive biomarker in metastatic colorectal cancer.
作者信息
Ramos Francisco Javier, Tabernero Josep
出版信息
Biomark Med. 2008 Apr;2(2):97-9. doi: 10.2217/17520363.2.2.97.
PMID:20477429
Abstract
摘要
相似文献
1
K-Ras mutation status as a predictive biomarker in metastatic colorectal cancer.K-Ras突变状态作为转移性结直肠癌的预测性生物标志物。
Biomark Med. 2008 Apr;2(2):97-9. doi: 10.2217/17520363.2.2.97.
2
Ischemia-induced K-ras mutations in human colorectal cancer cells: role of microenvironmental regulation of MSH2 expression.缺血诱导的人结肠癌细胞K-ras突变：MSH2表达的微环境调节作用
Cancer Res. 2005 Sep 15;65(18):8134-41. doi: 10.1158/0008-5472.CAN-05-0713.
3
Keratin 20 is a specific marker of submicroscopic lymph node metastases in colorectal cancer: validation by K-RAS mutations.角蛋白20是结直肠癌亚微观淋巴结转移的特异性标志物：通过K-RAS突变进行验证
J Pathol. 2000 May;191(1):21-6. doi: 10.1002/(SICI)1096-9896(200005)191:1<21::AID-PATH581>3.0.CO;2-S.
4
K-ras gene mutations in normal colorectal tissues from K-ras mutation-positive colorectal cancer patients.K-ras基因变异阳性结直肠癌患者正常结直肠组织中的K-ras基因突变
Cancer Res. 1997 Jun 15;57(12):2485-92.
5
Low somatic K-ras mutation frequency in colorectal cancer diagnosed under the age of 45 years.45岁以下诊断出的结直肠癌中体细胞K-ras突变频率较低。
Eur J Cancer. 2006 Jul;42(10):1357-61. doi: 10.1016/j.ejca.2006.02.023. Epub 2006 Jun 9.
6
Suppression of colorectal cancer growth using an adenovirus vector expressing an antisense K-ras RNA.使用表达反义K-ras RNA的腺病毒载体抑制结直肠癌生长。
Mol Ther. 2001 Apr;3(4):491-9. doi: 10.1006/mthe.2001.0302.
7
K-Ras mutations and treatment outcome in colorectal cancer patients receiving exclusive fluoropyrimidine therapy.接受单纯氟嘧啶治疗的结直肠癌患者的K-Ras突变与治疗结果
Clin Cancer Res. 2008 Aug 1;14(15):4830-5. doi: 10.1158/1078-0432.CCR-07-4906.
8
Relevance of Ki-67 antigen expression and K-ras mutation in colorectal liver metastases.Ki-67抗原表达及K-ras突变在结直肠癌肝转移中的相关性
Eur J Surg Oncol. 2001 Feb;27(1):80-7. doi: 10.1053/ejso.2000.1029.
9
10
K-ras gene mutation is a useful predictor of the survival of early stage colorectal cancers.K-ras基因突变是早期结直肠癌生存情况的一个有用预测指标。
Anticancer Res. 1996 Nov-Dec;16(6B):3839-44.
引用本文的文献
1
Detection of K-ras Mutations in Predicting Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase (EGFR-TK) Inhibitor in Patients with Metastatic Colorectal Cancer.检测K-ras突变对预测转移性结直肠癌患者表皮生长因子受体酪氨酸激酶（EGFR-TK）抑制剂疗效的作用
PLoS One. 2015 May 7;10(5):e0101019. doi: 10.1371/journal.pone.0101019. eCollection 2015.
Zotero 插件